Monopar to Present at the H.C. Wainwright BioConnect Conference
07 janv. 2022 07h05 HE
|
Monopar Therapeutics Inc.
WILMETTE, Ill., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to...
NeuroMetrix to Present at H.C. Wainwright BioConnect Conference 2022
05 janv. 2022 09h00 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, will be presenting at the...
aTyr Pharma to Present at H.C. Wainwright Virtual BioConnect Conference
04 janv. 2022 08h03 HE
|
aTyr Pharma, Inc.
SAN DIEGO, Jan. 04, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological...
Processa Pharmaceuticals to Present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference
11 janv. 2021 10h50 HE
|
Processa Pharmaceuticals, Inc.
HANOVER, MD., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to...